ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Zylox-Tonbridge Medical Technology Co., Ltd.
Equities
2190
CNE100004JD2
Medical Equipment, Supplies & Distribution
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.48 HKD | -0.21% |
|
+0.85% | -23.79% |
| Mar. 22 | Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 | MT |
| Mar. 21 | Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Zylox-Tonbridge Medical Technology Co Ltd, formerly Zylox Medical Device Co Ltd, is a China-based company mainly engaged in the research and development of neurological and peripheral vascular interventional medical devices. The Company's main products include Thrombite Clot Retriever Device (Thrombite CRD) and Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB). The Company's products are sold to domestic and foreign markets.
Calendar
2024-08-25
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
8.763
CNY
Average target price
14.11
CNY
Spread / Average Target
+61.00%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.79% | 397M | |
| +9.35% | 128B | |
| -10.36% | 10.42B | |
| -1.13% | 8.81B | |
| +18.54% | 7.38B | |
| +19.68% | 4.86B | |
| +7.75% | 3.43B | |
| -1.34% | 3.08B | |
| -16.08% | 2.01B | |
| -12.31% | 1.96B |
- Stock Market
- Equities
- 2190 Stock
- News Zylox-Tonbridge Medical Technology Co., Ltd.
- Zylox Tonbridge Medical Technology : Tonbridge Completes Patient Enrollment in Stent's Clinical Trial
